Schaeffer's Top Stock Picks for '25

Acadia Stock Rallies On Big FDA Approval

ACAD stock is on track for its best day since Aug. 9

Managing Editor
Jun 29, 2018 at 9:57 AM
facebook X logo linkedin


ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) stock is up 11.5% to trade at $16.80, after the Food and Drug Administration (FDA) approved new capsule dosing formulation and tablet strength for Nuplazid, the company's treatment for Parkinson's disease. ACAD is now pacing for its best day since Aug. 9. 

Today's surge runs counter to ACADIA Pharmaceuticals stock's longer-term trend. Heading into today's trading, the equity was down 50% as of yesterday's close. In fact, the shares have been lingering near four-year-low territory since a scathing CNN report on Nuplazid in early April. Plus, today's upside gap is being contained by familiar resistance at the 50-day moving average.

Nevertheless, analysts have kept the faith in the drugmaker. All four of the brokerages in coverage rate ACAD a "strong buy." What's more, the stock's average 12-month price target of $47.29 is a whopping 180% premium to the stock's current perch.

Short sellers, on the other hand, have been ramping up the skepticism on ACAD. Short interest increased by 20% in the most recent reporting period to 15.21 million shares, the most since September. This represents almost 16% of ACAD's total available float, and six times its average daily trading volume. Some of today's gains could be a result of the weaker bearish hands throwing in the towel.

Some of these shorts may have initiated options hedges to guard against any upside risk. The out-of-the-money July 18 call saw the largest increase in open interest during the last 10 sessions, and data from Trade-Alert points to buy-to-open activity.

 
 

You have the chance to join one of Bernie's most exclusive programs, complete access at HUGE savings!

As we prepare for a new administration to take the reins in Washington, the near-term market landscape is rife with uncertainty.

The Federal Reserve has already hinted at the turbulence ahead, lowering its interest rate outlook for 2025.

Meanwhile, breakthroughs in artificial intelligence (AI), quantum computing, and other transformative sectors have unlocked incredible profit potential.

But these opportunities are fleeting, and timing is everything. That's where Quick-Hit Trader comes in.

Quick-Hit Trader is designed for precision and speed, getting you in and out of the market in a flash. While other investors scramble to navigate volatile conditions, you'll have access to expertly curated trades that leverage these rapid shifts to deliver explosive profits in short order.

This is your chance to capitalize on the fast-moving market like never before. Are you ready to make your move?